These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9598652)

  • 21. Management of the post chemotherapy subcentimeter residual mass: the case for observation.
    Beck SD; Foster RS
    World J Urol; 2009 Aug; 27(4):485-8. PubMed ID: 19603172
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumours.
    Oliver RT; Dhaliwal HS; Hope-Stone HF; Blandy JP
    Br J Urol; 1988 Jan; 61(1):53-8. PubMed ID: 2449257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence of a non-seminomatous germ cell tumor in the seminal vesicle 20 years after initial diagnosis and treatment.
    Lattouf JB; Mc Cormack M; Yelle L; Hadjeres R; Saad F
    Can J Urol; 2004 Aug; 11(4):2350-1. PubMed ID: 15380057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
    Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
    J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.
    Toner GC; Stockler MR; Boyer MJ; Jones M; Thomson DB; Harvey VJ; Olver IN; Dhillon H; McMullen A; Gebski VJ; Levi JA; Simes RJ
    Lancet; 2001 Mar; 357(9258):739-45. PubMed ID: 11253966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curative, platinum-based cytoxic drug therapy in a renal transplant recipient with metastatic testicular cancer.
    Osiason AW; Polackwich RJ
    Cancer; 1986 Aug; 58(4):850-1. PubMed ID: 2424586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncological outcomes of metastatic testicular cancers under centralized management through regional medical network.
    Inai H; Kawai K; Kojima T; Joraku A; Shimazui T; Yamauchi A; Miyagawa T; Endo T; Fukuhara Y; Miyazaki J; Uchida K; Nishiyama H
    Jpn J Clin Oncol; 2013 Dec; 43(12):1249-54. PubMed ID: 24101656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemorrhagic cystitis after i.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer.
    Cantwell BM; Harris AL; Patrick D; Hall RR
    Cancer Treat Rep; 1986 Apr; 70(4):548-9. PubMed ID: 2421895
    [No Abstract]   [Full Text] [Related]  

  • 33. Failure of adjuvant chemotherapy in testicular cancer.
    Bernstein JI; Freiha F; Breeden J; Torti FM
    Cancer; 1987 Oct; 60(8):1729-30. PubMed ID: 2443231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy of testicular cancer].
    Witjes JA; Debruyne FM
    Ned Tijdschr Geneeskd; 1999 Mar; 143(11):557-60. PubMed ID: 10321273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growing teratoma syndrome after chemotherapy for germ cell tumour of the ovary.
    Tejura H; O'Leary A
    J Obstet Gynaecol; 2005 Apr; 25(3):296-7. PubMed ID: 16147741
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapy for good-risk germ-cell tumors.
    Ryan CJ; Bajorin DF
    Semin Urol Oncol; 2002 Nov; 20(4):244-50. PubMed ID: 12489057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug dose delivery and treatment outcome relationship in standard bleomycin, etoposide and cisplatin combination chemotherapy in nonseminomatous germ cell tumor patients.
    Gutierrez-Delgado F; Titov DA; Tjulandin SA; Garin AM
    Neoplasma; 1999; 46(3):190-5. PubMed ID: 10613596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.